Chemical Structure (Image 1)
Octreotide Acetate
Product Images NDC 63629-8831
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 63629-8831). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Lbl636298831)
Octreotide Acetate Injection is a medication used for subcutaneous injection. The vial contains 100mcg of octreotide acetate along with glacial acetic acid, USP 2.0 mg, sodium acetate trihydrate, USP 2.0 mg, mannitol, USP 45mg and water for injection, USP, gs. Glacial acetic acid, USP and sodium acetate trihydrate, USP are added to provide a buffered solution that maintains a pH of 4.2±0.5. It is recommended to store it in a refrigerator between 2°C and 8°C and protect it from light. Octreotide Acetate Injection is stable for 14 days if protected from light when stored at room temperature, (20°C to 30°C or70°F to 86°F). One box contains 25 single-dose vials.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
